Blood glucose concentration and outcome of critical illness: The impact of diabetes*

Objective:To study the impact of diabetes mellitus on the relationship between glycemia and mortality in critically ill patients. Design:Retrospective observational study. Setting:Intensive care units of two university hospitals. Patients:Cohort of 4946 critically ill patients including 728 patients with diabetes mellitus. Intervention:None. Measurements and Main Results:We assessed and compared the relationship between glycemia during intensive care unit stay and mortality in diabetic and nondiabetic patients. There were 125,036 blood glucose measurements (5.7 measurements/day on average). Intensive care unit mortality increased significantly with increasing mean blood glucose concentration in nondiabetes mellitus patients but not in diabetes mellitus patients. Nondiabetes mellitus patients with a time-weighted glucose concentration (GluTw) between 8.0 and 10.0 mmol/L were found to be 1.74 times more likely to die in intensive care unit as diabetes mellitus patients in the same range (odds ratio = 1.74 [1.13–2.68] p = 0.01). They were also more than three times more likely to die in the intensive care unit compared with diabetes mellitus patients when the Glutw was between 10.0 and 11.1 mmol/L (odds ratio = 3.34 [1.35–8.23] p = 0.009). Using multivariate logistic regression analysis, hyperglycemia was strongly and independently associated with outcome in nondiabetic patients (p < 0.001) but showed no significant association with outcome in diabetic patients. Conclusions:Unlike nondiabetic patients, diabetic patients show no clear association between hyperglycemia during intensive care unit stay and mortality and markedly lower odds ratios of death at all levels of hyperglycemia. These findings suggest that, in critically patients with diabetes mellitus, hyperglycemia may have different biological and/or clinical implications. LEARNING OBJECTIVESOn completion of this article, the reader should be able to: Explain the impact of blood glucose monitoring on outcomes. Describe the impact of the diagnosis of diabetes on outcomes in patients with hyperglycemia. Use this information in a clinical setting. Dr. French has disclosed that he was the recipient of grant/research funds from Novartis and is currently receiving grant/research funds from Novartis, Wyeth, Lilly, and Takeda. Dr. French has disclosed that he was a consultant/advisor for Wyeth. The remaining authors have disclosed that they have no financial relationships with or interests in any commercial companies pertaining to this educational activity. All faculty and staff in a position to control the content of this CME activity have disclosed that they have no financial relationship with, or financial interests in, any commercial companies pertaining to this educational activity. Lippincott CME Institute, Inc., has identified and resolved all faculty conflicts of interest regarding this educational activity. Visit the Critical Care Medicine Web Site (www.ccmjournal.org) for information on obtaining continuing medical education credit.

[1]  P. Stow,et al.  Safety and feasibility of an insulin adjustment protocol to maintain blood glucose concentrations within a narrow range in critically ill patients in an Australian level III adult intensive care unit. , 2004, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[2]  Daniel J. Johnson,et al.  Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. , 2005, Mayo Clinic proceedings.

[3]  A. Shuaib.  Alteration of blood pressure regulation and cerebrovascular disorders in the elderly. , 1992, Cerebrovascular and brain metabolism reviews.

[4]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[5]  R. Bellomo,et al.  A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. , 2006, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[6]  C. Hann,et al.  Rethinking glycaemic control in critical illness--from concept to clinical practice change. , 2006, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[7]  R. Wolfe,et al.  Glucose metabolism in man: responses to intravenous glucose infusion. , 1979, Metabolism: clinical and experimental.

[8]  J. Krinsley.  Glycemic control in critically ill patients: Leuven and beyond. , 2007, Chest.

[9]  R. Schiele,et al.  Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study , 2003, Acta Diabetologica.

[10]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[11]  M. Mlynarek,et al.  An Insulin Infusion Protocol in Critically Ill Cardiothoracic Surgery Patients , 2004, The Annals of pharmacotherapy.

[12]  L. Robinson,et al.  Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. , 2004, AACN clinical issues.

[13]  Rinaldo Bellomo,et al.  Development and implementation of a high-quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database. , 2006, Journal of critical care.

[14]  Howard Cabral,et al.  Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events , 2004, Circulation.

[15]  D. Coursin,et al.  Perioperative diabetic and hyperglycemic management issues , 2004, Critical care medicine.

[16]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[17]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[18]  N. Doll,et al.  Impact of Diabetes Mellitus on Cardiac Surgery Outcome , 2003, The Thoracic and cardiovascular surgeon.

[19]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[20]  Rinaldo Bellomo,et al.  Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. , 2005, Mayo Clinic proceedings.

[21]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[22]  A. May,et al.  The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. , 2005, JPEN. Journal of parenteral and enteral nutrition.

[23]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[24]  D. Smallwood,et al.  The effects of oxygen therapy in patients presenting to an emergency department with exacerbation of chronic obstructive pulmonary disease , 2007, The Medical journal of Australia.

[25]  Miet Schetz,et al.  Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units , 2006, Diabetes.

[26]  K. Malmberg.  Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[27]  R. Wolfe,et al.  Differentiation between septic and postburn insulin resistance. , 1989, Metabolism: clinical and experimental.

[28]  M. Degeorgia,et al.  Neurologic effects of hyponatremia and its treatment. , 2007, Cleveland Clinic journal of medicine.

[29]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[30]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.